We are live on ! Find out more
MG

Michael Gelband ExodusPoint Capital Management

AUM $15.5B
1-Year Est. Return 38.81%
 

Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.

This Fund
S&P 500
This Quarter Est. Return
+18.5%
1 Year Est. Return
+38.81%
3 Year Est. Return
+110.53%
5 Year Est. Return
+124.16%
10 Year Est. Return
AUM
$15.5B
AUM Growth
+$2.94B
Cap. Flow
+$1.45B
Cap. Flow %
9.35%
Top 10 Hldgs %
30.63%
Holding
2,230
New
735
Increased
384
Reduced
378
Closed
720

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$614M
2
AAPL icon
Apple
AAPL
+$443M
3
BLD
TopBuild
BLD
+$391M
4
SPCX
SpaceX
SPCX
+$329M
5
PEN icon
Penumbra
PEN
+$203M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$1.96B
2
NVDA icon
NVIDIA
NVDA
+$425M
3
SNDK
Sandisk
SNDK
+$88M
4
SO icon
Southern Company
SO
+$80.6M
5
PPL
PPL Corp
PPL
+$74.1M

Sector Composition

Rank Sector Weight
1 Technology 16.4%
2 Industrials 13.64%
3 Consumer Discretionary 9.5%
4 Healthcare 7.9%
5 Financials 5.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IMVT icon
1801
Immunovant
IMVT
$9.16B
-21,941
Closed -$545K
INSW icon
1802
International Seaways
INSW
$4.93B
-34,038
Closed -$2.48M
INTC icon
1803
CALL
Intel
INTC
$476B
-4,500
Closed -$199K
INTR icon
1804
Inter&Co
INTR
$2.38B
-340,856
Closed -$2.71M
IONQ icon
1805
CALL
IonQ
IONQ
$18.2B
-6,600
Closed -$190K
IREN icon
1806
Iris Energy
IREN
$15B
-187,913
Closed -$6.44M
IRMD icon
1807
iRadimed
IRMD
$1.12B
-15,423
Closed -$1.48M
ITRI icon
1808
Itron
ITRI
$4.38B
-6,407
Closed -$574K
ITW icon
1809
Illinois Tool Works
ITW
$80.4B
-18,480
Closed -$4.81M
IVA
1810
Inventiva
IVA
$1.11B
-38,256
Closed -$212K
IVT icon
1811
InvenTrust Properties
IVT
$2.55B
-33,584
Closed -$1.02M
IVVD icon
1812
Invivyd
IVVD
$294M
-25,786
Closed -$33.5K
IWM icon
1813
CALL
iShares Russell 2000 ETF
IWM
$81.9B
-80,000
Closed -$19.5M
IWM icon
1814
iShares Russell 2000 ETF
IWM
$81.9B
-8,125
Closed -$2.28M
JKHY icon
1815
Jack Henry & Associates
JKHY
$11.8B
-32,714
Closed -$5.17M
JMIA
1816
Jumia Technologies
JMIA
$840M
-11,631
Closed -$80.3K
JPM icon
1817
JPMorgan Chase
JPM
$935B
-28,046
Closed -$8.25M
KAI icon
1818
Kadant
KAI
$3.7B
-1,982
Closed -$579K
KALU icon
1819
Kaiser Aluminum
KALU
$2.52B
-9,763
Closed -$1.18M
KALV
1820
DELISTED
KalVista Pharmaceuticals
KALV
-177,274
Closed -$3.57M
KBR icon
1821
KBR
KBR
$4.86B
-167,412
Closed -$6.17M
KFRC icon
1822
Kforce
KFRC
$1.05B
-15,317
Closed -$448K
KGS icon
1823
Kodiak Gas Services
KGS
$6.21B
-10,336
Closed -$603K
KHC icon
1824
Kraft Heinz
KHC
$30.3B
-306,949
Closed -$6.9M
KIDS icon
1825
OrthoPediatrics
KIDS
$670M
-34,961
Closed -$555K

Similar funds

Michael Gelband's Q2 2026 Portfolio in Review

As of Q2 2026, Michael Gelband held 2,230 positions worth $15.5B, up 23% from $12.6B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Michael Gelband deployed $1.45B of net new capital in Q2 2026, opening 735 new positions and adding to 384 existing holdings. Its largest new stake was SpaceX: 1,938,935 shares worth $331M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 14% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Tesla, an estimated $1.96B trimmed.

  • Michael Gelband's largest Q2 2026 buy was SpaceX: 1,938,935 shares worth $331M.
  • Michael Gelband added most to Amazon in Q2 2026, an estimated $614M increase.
  • Michael Gelband's biggest Q2 2026 reduction was Tesla, cutting an estimated $1.96B.
  • Michael Gelband fully exited Southern Company in Q2 2026, selling an estimated $80.6M.
  • Michael Gelband's ten largest holdings make up 31% of its $15.5B portfolio in Q2 2026.
  • Michael Gelband opened 735 new positions and closed 720 in Q2 2026.
  • Michael Gelband's portfolio value rose 23% quarter-over-quarter to $15.5B.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.